These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31851776)
1. VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02). Feliu J; Garcia-Carbonero R; Capdevila J; Guasch I; Alonso-Orduna V; Lopez C; Garcia-Alfonso P; Castanon C; Sevilla I; Cerezo L; Conill C; Quintana-Angel B; Sanchez ME; Ghanem I; Martin-Richard M; Lopez-Gomez M; Leon A; Caro M; Fernandez T; Maurel J Cancer Med; 2020 Feb; 9(3):1008-1016. PubMed ID: 31851776 [TBL] [Abstract][Full Text] [Related]
2. PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer. Zimmermann M; Beer J; Bodis S; von Moos R; Vlachopoulou V; Zwahlen DR; Oehler C Acta Oncol; 2017 Dec; 56(12):1734-1740. PubMed ID: 28557585 [TBL] [Abstract][Full Text] [Related]
3. Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904). Vendrely V; Lemanski C; Gnep K; Barbier E; Hajbi FE; Lledo G; Dahan L; Terrebonne E; Manfredi S; Mirabel X; Mammar V; Cowen D; Lepage C; Aparicio T; Radiother Oncol; 2019 Nov; 140():84-89. PubMed ID: 31185328 [TBL] [Abstract][Full Text] [Related]
4. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. Flam M; John M; Pajak TF; Petrelli N; Myerson R; Doggett S; Quivey J; Rotman M; Kerman H; Coia L; Murray K J Clin Oncol; 1996 Sep; 14(9):2527-39. PubMed ID: 8823332 [TBL] [Abstract][Full Text] [Related]
5. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Vendrely V; Ronchin P; Minsat M; Le Malicot K; Lemanski C; Mirabel X; Etienne PL; Lièvre A; Darut-Jouve A; de la Fouchardière C; Giraud N; Breysacher G; Argo-Leignel D; Thimonnier E; Magné N; Abdelghani MB; Lepage C; Aparicio T; Radiother Oncol; 2023 Sep; 186():109742. PubMed ID: 37315583 [TBL] [Abstract][Full Text] [Related]
6. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study. Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146 [TBL] [Abstract][Full Text] [Related]
7. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer. Leon O; Guren MG; Radu C; Gunnlaugsson A; Johnsson A Eur J Cancer; 2015 Dec; 51(18):2740-6. PubMed ID: 26597443 [TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal. Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial). Murofushi KN; Itasaka S; Shimokawa M; Murakami Y; Yamamoto T; Nishimura Y; Kudo S; Sakamoto T; Ariga T; Ogo E; Taguchi K; Jingu K; Ogawa K J Radiat Res; 2023 Jan; 64(1):154-161. PubMed ID: 36280895 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. Kachnic LA; Winter KA; Myerson RJ; Goodyear MD; Abitbol AA; Streeter OE; Augspurger ME; Schefter TE; Katz AW; Fisher BJ; Henke LE; Narayan S; Crane CH Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):146-157. PubMed ID: 34400269 [TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C. White EC; Goldman K; Aleshin A; Lien WW; Rao AR Radiother Oncol; 2015 Nov; 117(2):240-5. PubMed ID: 26347494 [TBL] [Abstract][Full Text] [Related]
12. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Kachnic LA; Winter K; Myerson RJ; Goodyear MD; Willins J; Esthappan J; Haddock MG; Rotman M; Parikh PJ; Safran H; Willett CG Int J Radiat Oncol Biol Phys; 2013 May; 86(1):27-33. PubMed ID: 23154075 [TBL] [Abstract][Full Text] [Related]
13. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients]. Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808 [TBL] [Abstract][Full Text] [Related]
15. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. Gunderson LL; Winter KA; Ajani JA; Pedersen JE; Moughan J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG J Clin Oncol; 2012 Dec; 30(35):4344-51. PubMed ID: 23150707 [TBL] [Abstract][Full Text] [Related]
16. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. Glynne-Jones R; Kadalayil L; Meadows HM; Cunningham D; Samuel L; Geh JI; Lowdell C; James R; Beare S; Begum R; Ledermann JA; Sebag-Montefiore D; Ann Oncol; 2014 Aug; 25(8):1616-22. PubMed ID: 24827136 [TBL] [Abstract][Full Text] [Related]
17. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Glynne-Jones R; Meadows H; Wan S; Gollins S; Leslie M; Levine E; McDonald AC; Myint S; Samuel L; Sebag-Montefiore D; Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):119-26. PubMed ID: 18472366 [TBL] [Abstract][Full Text] [Related]
18. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Peiffert D; Giovannini M; Ducreux M; Michel P; François E; Lemanski C; Mirabel X; Cvitkovic F; Luporsi E; Conroy T; Gérard JP; Ann Oncol; 2001 Mar; 12(3):397-404. PubMed ID: 11332154 [TBL] [Abstract][Full Text] [Related]
19. Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer. Joseph K; Nijjar Y; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Ghosh S; Syme A; Nijjar T; Mulder K; Doll C; Wong C; Field C Radiother Oncol; 2015 Nov; 117(2):234-9. PubMed ID: 26306677 [TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Meulendijks D; Dewit L; Tomasoa NB; van Tinteren H; Beijnen JH; Schellens JH; Cats A Br J Cancer; 2014 Oct; 111(9):1726-33. PubMed ID: 25167226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]